TBP Study With Capecitabine Plus Minus Trastuzumab
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Capecitabine|DRUG: Trastuzumab
Sponsor: German Breast Group
Collaborators: Hoffmann-La Roche